文献速递神经介入DSACT

稀释n-BCA联合5%葡萄糖推注技术栓塞脑膜中动脉治疗慢性硬膜下血肿的前瞻性安全性与可行性研究

Middle Meningeal Artery Embolization Using Combined Particle Embolization and n-BCA with the Dextrose 5% in Water Push Technique for Chronic Subdural Hematomas: A Prospective Safety and Feasibility Study.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-03-04

本研究前瞻性纳入16例慢性难治性或复发性硬膜下血肿患者,评估稀释n-BCA(与碘化油1:6)联合5%葡萄糖推注技术行脑膜中动脉栓塞的安全性与技术可行性。结果显示所有病例均无术中或术后并发症,脑膜中动脉分支远端穿透均成功,7天随访CT示60%(9/15)患者血肿体积缩小>50%,21天进一步改善(>75%缩小)。结论认为该技术安全可行,5%葡萄糖推注有助于提高胶的远端穿透。

要点

  • 稀释n-BCA(1:6碘化油)栓塞脑膜中动脉技术可行,本组无术中或术后并发症。
  • 5%葡萄糖推注技术可实现脑膜中动脉分支远端穿透,所有病例均成功。
  • 7天随访约60%患者血肿体积缩小>50%,21天随访进一步缩小>75%。

关键影像表现/征象

  • 所有病例均实现脑膜中动脉分支远端穿透。
  • 7天随访头颅CT示9/15(60%)患者血肿体积缩小>50%,6/15(40%)血肿无变化或稳定。
  • 21天随访 available CT 示血肿体积进一步显著缩小(>75%)。

诊断标准与关键数值

  • 技术成功定义为实现脑膜中动脉分支远端穿透,本组所有病例均达到。
  • 安全性终点为无术中或术后并发症,本组100%病例达到。
  • 疗效评估采用血肿体积缩小比例:7天>50%为改善,21天>75%为进一步改善。

临床应用与阅片要点

  • 对于慢性难治性或复发性硬膜下血肿,可考虑采用稀释n-BCA(1:6碘化油)联合5%葡萄糖推注行脑膜中动脉栓塞。
  • 术中应追求脑膜中动脉分支的远端穿透,5%葡萄糖推注有助于胶的远端弥散。
  • 术后7天及21天随访CT可用于评估血肿体积变化,部分患者血肿可能稳定或无明显缩小。

局限性

  • 样本量小(16例),单中心前瞻性研究,未设对照组。
  • 部分患者(12/16)同时行钻孔引流术,可能 confounding 疗效评估。
  • 随访时间短,长期疗效及复发率未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Embolization of the middle meningeal artery for treatment of refractory or recurrent chronic subdural hematomas has gained momentum during the past few years. Little has been reported on the use of the n-BCA liquid embolic system for middle meningeal artery embolization. We present the technical feasibility of using diluted n-BCA for middle meningeal artery embolization.

MATERIALS AND METHODS: We sought to examine the safety and technical feasibility of the diluted n-BCA liquid embolic system for middle meningeal artery embolization. Patients with chronic refractory or recurrent subdural hematomas were prospectively enrolled from September 2019 to June 2020. The primary outcome was the safety and technical feasibility of the use of diluted n-BCA for embolization of the middle meningeal artery. The secondary end point was the efficacy in reducing hematoma volume.

RESULTS: A total of 16 patients were prospectively enrolled. Concomitant burr-hole craniotomies were performed in 12 of the 16 patients. Two patients required an operation following middle meningeal artery embolization for persistent symptoms. The primary end point was met in 100% of cases in which there were no intra- or postprocedural complications. Distal penetration of the middle meningeal artery branches was achieved in all the enrolled cases. A 7-day post-middle meningeal artery embolization follow-up head CT demonstrated improvement (>50% reduction in subdural hematoma volume) in 9/15 (60%) patients, with 6/15 (40%) showing an unchanged or stable subdural hematoma. At day 21, available CT scans demonstrated substantial further improvement (>75% reduction in subdural hematoma volume).

CONCLUSIONS: Embolization of the middle meningeal artery using diluted n-BCA and ethiodized oil (1:6) is safe and feasible from a technical standpoint. The use of a dextrose 5% bolus improves distal penetration of the glue.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Al-Mufti F, Kaur G, Amuluru K, et al. Middle Meningeal Artery Embolization Using Combined Particle Embolization and n-BCA with the Dextrose 5% in Water Push Technique for Chronic Subdural Hematomas: A Prospective Safety and Feasibility Study. AJNR Am J Neuroradiol. 2021. PMID: 33664110. doi:10.3174/ajnr.A7077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。